Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,570 Prostate Cancer
clinical trials

Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Community Medical Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Medical Center
mi
from
Modesto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Toledo Clinic Cancer Centers - Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Good Samaritan Regional Health Center
mi
from
Mount Vernon, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Palo Alto Medical Foundation-Camino Division
mi
from
Mountain View, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Louisiana State University Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
New Ulm Medical Center
mi
from
New Ulm, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Alegent Health Lakeside Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial GYN Plus
mi
from
Ooltewah, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Midlands Community Hospital
mi
from
Papillion, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Pennsylvania:Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC-Saint Margaret
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Huron Medical Center
mi
from
Port Huron, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Princeton
mi
from
Princeton, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Radiation Oncology Associates
mi
from
Reno, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Kootenai Cancer Clinic
mi
from
Sandpoint, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital Springfield
mi
from
Springfield, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakeview Hospital
mi
from
Stillwater, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Missouri Baptist Outpatient Center-Sunset Hills
mi
from
Sunset Hills, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC Uniontown Hospital Radiation Oncology
mi
from
Uniontown, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital Washington
mi
from
Washington, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Methodist West Hospital
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Prostate Adenocarcinoma Clinical Trial
Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Emily Couric Clinical Cancer Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Chicago Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib Plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Metastatic or Surgically Unresectable Urothelial Cancer With Selected FGFR Gene Alterations
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Univ of Iowa Hosp and Clinic
mi
from
Iowa City, IA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib Plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Metastatic or Surgically Unresectable Urothelial Cancer With Selected FGFR Gene Alterations
Status: Enrolling, Phase I, II
Updated: 12/31/1969
St. Luke's University Health Network
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib Plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Metastatic or Surgically Unresectable Urothelial Cancer With Selected FGFR Gene Alterations
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib Plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Metastatic or Surgically Unresectable Urothelial Cancer With Selected FGFR Gene Alterations
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer (mCRPC) Clinical Trial
ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer (mCRPC) Clinical Trial
ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer (mCRPC) Clinical Trial
ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Icahn School of Medicine at Mt Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer (mCRPC) Clinical Trial
ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Maryland Oncology Hematology, P.A.
mi
from
Rockville, MD
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer (mCRPC) Clinical Trial
ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Toledo Clinic Cancer Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer (mCRPC) Clinical Trial
ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alaska Clinical Research Center, LLC
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
Nebraska Cancer Specialists
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
FPA150 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
FPA150 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
FPA150 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)
Status: Enrolling, Phase II
Updated: 12/31/1969
Honor Health
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Testing for Men With Metastatic Prostate Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Single Arm Study of 6-Months Neoadjuvant ARN-509 Prior to Radical Prostatectomy
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Prostate Cancer Metastatic Clinical Trial
Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
Status: Enrolling, Phase III
Updated: 12/31/1969
Alaska Urological Institute DBA Alaska Clinical Research Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Status: Enrolling, Phase II
Updated: 12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Gettysburg Cancer Center
mi
from
Gettysburg, PA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Chesapeake Urology Research Associates
mi
from
Towson, MD
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Prostatic Neoplasm Clinical Trial
177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Wisconsin Clinical Science Center
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Cancer of the PROSTATE Clinical Trial
Proton Boost in Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Trastuzumab Deruxtecan (DS-8201a) With Nivolumab in Advanced Breast and Urothelial Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Norton Cancer Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Status: Enrolling, Phase IV
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
GU Research Network, LLC/ Urology Cancer Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
Status: Enrolling, Phase I
Updated: 12/31/1969
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Castration-Resistant Prostatic Neoplasms Clinical Trial
A Study of JNJ-63723283, a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California at Los Angeles - UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
COMbination of Bipolar Androgen Therapy and Nivolumab
Status: Enrolling, Phase II
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Improving Evidence-Based Care for Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
Status: Enrolling, Phase IV
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
This Study is to Evaluate OBI-3424 Safe and Effective Treatment Dose in Subjects With Hepatocellular Carcinoma or Castrate Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mary Crowley Cancer Research Centers - Medical City
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Florida Cancer Specialists & Research Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
Oncology Clinical Trial
EXERCISING TOGETHER© for Couples Coping With Cancer
Status: Enrolling
Updated: 12/31/1969
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Sitravatinib and Nivolumab in Urothelial Carcinoma Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology-Austin Central
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Sitravatinib and Nivolumab in Urothelial Carcinoma Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Status: Enrolling, Phase I, II
Updated: 12/31/1969
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Prostate Cancer Metastatic Clinical Trial
Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Urology Clinics of North Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Prostate Cancer Metastatic Clinical Trial
Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Premier Urology Group
mi
from
Edison, NJ
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Mississippi
mi
from
Jackson, MS
Click here to add this to my saved trials
Oncology Clinical Trial
The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence
Status: Enrolling, Phase II
Updated: 12/31/1969
Urology Center of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
1 … 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 … 66